Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Icon Acquires MolecularMD

Icon Acquires MolecularMD

Feb 21, 2019
|
staff reporter

This article has been updated from a previous version to correct Icon's international headquarters location.

NEW YORK (GenomeWeb) – Icon, an international drug-development and commercialization services firm, has acquired MolecularMD for an undisclosed amount, the companies said today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
22
Featured Webinar

Trends in Variant Interpretation Workflows: Expert Insights to Advance NGS Oncology Profiling

Sponsored by
Qiagen

Please join GenomeWeb and Qiagen for an online roundtable discussion where a panel of experts will review challenges and opportunities around genomic variant interpretation workflows in the field of oncology.

What's Popular?

In Cancer

  1. NeoGenomics to Boost Growth of Pharma, Informatics Divisions Through CDx Agreements, Acquisitions

    Premium

  2. Caris Shares Data for AI-Driven Tumor Origin Prediction, Hinting at Diagnostic, Patient Benefit

    Premium

  3. Todos Medical Obtains $3.4M Investment From Yozma Group Korea

  4. Oppenheimer Initiates Coverage of DermTech With Outperform Rating

  5. OncoLab Diagnostics Targets Cancer Recurrence Monitoring with CTC-Derived Biomarker Assay

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.